Daily Courier: Single Column

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Johnson & Johnson (NY:JNJ)

171.04 +3.71 (+2.22%)
Official Closing Price Updated: 7:00 PM EDT, Aug 4, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Johnson & Johnson

< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Pfizer's Ascent Signals Broader Health Sector Resilience Amidst Innovation Wave
In a notable shift, shares of Pfizer (NYSE: PFE) have recently edged higher, reflecting a burgeoning strength within the broader health sector. This uptick signals a renewed investor confidence in the... 
Via MarketMinute
Topics Artificial Intelligence Economy Intellectual Property
From AI To Emerging Markets: How 6 Pros Would Allocate $10K In Today's Market
 
Via Benzinga
Topics Artificial Intelligence
The 3 Things That Matter for Johnson & Johnson Now
Can the stock still deliver the same kinds of returns it has over the past few decades? 
Via The Motley Fool
Topics Bankruptcy Intellectual Property Lawsuit
Wall Street's Most Accurate Analysts Weigh In On 3 Health Care Stocks With Over 3% Dividend Yields
 
Via Benzinga
Trump Turns Up Heat On Big Pharma CEOs To Slash Drug Prices Within 60 Days — But Retail Traders Don't Flinch
Via Stocktwits
Topics Government
Microsoft, Meta Stocks Add $440 Billion In A Day—Nearly Matching Netflix's Entire $503 Billion Market Cap
Microsoft and Meta Platforms added over $400 billion in market capitalization after reporting robust earnings results on Wednesday. 
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
 
Via Benzinga
What's Going On With Eli Lilly Stock On Tuesday?
Eli Lilly stock slips after Novo Nordisk trims 2025 forecast; Jaypirca meets endpoint in CLL trial against J&J's Imbruvica, with more data expected. 
Via Benzinga
Drug Prices To Get 'More Expensive' Under Trump's EU Trade Deal As Pharma Faces Billions In Added Costs: Report
The pharmaceutical industry could face a significant financial hit due to the new trade deal between the U.S. and the European Union (EU), potentially leading to increased drug prices and restricted... 
Via Benzinga
Topics Government
2 Unstoppable Dow Dividend Stocks to Buy and Hold Forever
These top Dow dividend stocks have long dividend growth streaks. 
Via The Motley Fool
Topics Bonds Stocks
Got $1,000? 3 High-Yield Healthcare Stocks to Buy and Hold Forever
If you're looking for high-yield stocks in the healthcare sector, it's hard to beat this trio of industry giants offering yields of up to 3.9%. 
Via The Motley Fool
Topics Lawsuit
These 3 Dow Stocks Are Set to Soar in 2025 and Beyond
Plan now for a rotation away from riskier and volatile technology growth stocks and toward blue chips with more promise and predictability. 
Via The Motley Fool
Topics Artificial Intelligence Stocks
Palantir, Nvidia & Tempus AI Could Be Pharma ETF Darlings That Don't Make Pills
Sci-fi becomes reality: AI-native pharma disruptors like Palantir, Tempus, and Recursion are reshaping medicine. But ETFs still favor old-school giants. 
Via Benzinga
Topics Artificial Intelligence ETFs
3 Pharma Stocks That Aren't Sweating the Coming 200% Drug Tariffs
US President Trump imposed 200% tariff on pharmaceuticals affecting US drug prices and supply chain, but analysts say it may not happen soon. 
Via Benzinga
Topics Economy Government World Trade
AI Stocks and Options Selling: Is It Worth the Risk?
Artificial intelligence (AI) has become one of the most exciting and volatile sectors in the stock market. As companies like (NASDAQ:NVDA), (NASDAQ:PLTR), and (NASDAQ:TSLA) drive innovation in... 
Via MarketMinute
Topics Artificial Intelligence
Cash-Secured Puts: How to Get Paid to Buy Stocks at a Discount
In a market where volatility creates both fear and opportunity, income-focused investors are increasingly turning to a lesser-known but powerful strategy: selling cash-secured puts. This options... 
Via MarketMinute
4 Major Stocks Raise 2025 Guidance, Analyst Targets Rise
With solid Q2 results and 2025 guidance increases, Wall Street is upgrading these four stocks. Analysts now see palpable upside in one streaming stalwart. 
Via MarketBeat
What Is Considered a Good Stock Dividend? 2 Healthcare Stocks That Fit the Bill.
Via The Motley Fool
Topics Lawsuit Supply Chain
Trump Tariffs Forces AstraZeneca To Bring Substantial Pharmaceutical Production To US
AstraZeneca plans a $50 billion investment in U.S. facilities by 2030, including a Virginia plant focused on weight loss and metabolic drugs. 
Via Benzinga
Topics Government
Is the Stock Market in Bubble Territory?
Via The Motley Fool
Topics Artificial Intelligence
Apple's Online Store Is Now Live In Saudi Arabia, Flagship Stores Coming By 2026
Apple expands retail presence in Saudi Arabia by launching online store and app, offering personalized support and localized experience. 
Via Benzinga
Build Stability and Income With 3 Overlooked Dividend Leaders
Three dividend-paying stocks with high yields present an opportunity for significant passive income but a potentially high dividend payout ratio. 
Via MarketBeat
10 Magnificent S&P 500 Dividend Stocks Down Over 10% to Buy and Hold Forever
These S&P 500 dividend stocks have fallen by up to 33% and are best buys now. 
Via The Motley Fool
Topics Stocks
The Smartest Dividend Stock to Buy With $1,000 Right Now
Via The Motley Fool
Wall Street Sets New Records As Magnificent Seven Valuation Tops $18.5 Trillion: This Week In Markets
Wall Street rose to new heights during the week amid strong earnings and solid economic data. Meanwhile, Fed rate cut debate heats up. 
Via Benzinga
Topics Economy
Deal Dispatch: Del Taco Tanks, Tylenol Maker Aches For Change, Joyebells Burns The Pie
This week's M&A news includes strategic pivots and stumbles galore, with updates from WK Kellogg, Matador Restaurant and Windsurf. 
Via Benzinga
Stock Of The Day: Breakout In Johnson & Johnson
Shares of Johnson & Johnson broke out of a classic ascending triangle pattern. They have since stalled out at resistance. 
Via Benzinga
Want Steady Income? 3 Top Dividend Stocks for July 2025
Three dividend stocks stand out in July, offering reliable income, attractive yields, and strong fundamentals to help investors navigate market volatility 
Via MarketBeat
Topics Economy Lawsuit World Trade
Johnson & Johnson Ups Forecast, Beats On EPS—But Wall Street Is Cautious
Johnson & Johnson earnings came in 3% higher than consensus. The company's operating leverage was "slightly diluted by higher tax." 
Via Benzinga
Johnson & Johnson Analysts Raise Their Forecasts After Upbeat Earnings
 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

© Copyright 2015, Daily Courier, Kelowna, BC. Powered by BLOX Content Management System from TownNews.com.